Takeda Unit Inks Deal To End IP Suit After Bayer's $173M Win
Takeda Pharmaceutical unit Baxalta will stop fighting the $173 million in damages it was hit with two years ago for infringing Bayer's patent covering a hemophilia treatment after the two drugmakers managed...To view the full article, register now.
Already a subscriber? Click here to view full article